Performance Food beats Q1 profit estimates on higher prices, cases sold
Reuters2026/11/04 12:20
Overview
U.S. food distributor's fiscal Q1 net sales rose 5.5%, meets analyst expectations
Adjusted EPS for fiscal Q1 beat analyst expectations, rising 11.9% yr/yr
Company cites higher case volume, inflation-driven pricing, and acquisitions for profit growth
Outlook
Performance Food reiterates full-year fiscal 2027 net sales guidance of $72.5 bln to $73.0 bln
Company maintains full-year fiscal 2027 Adjusted EBITDA outlook of $2.125 bln to $2.225 bln
Performance Food expects Q2 net sales of $17.0 bln to $17.2 bln and Adjusted EBITDA of $490 mln to $510 mln
Result Drivers
CASE VOLUME GROWTH - Co attributed higher net sales and profit to increased total and independent Foodservice case volumes
INFLATION-DRIVEN PRICING - Co said net sales benefited from higher selling prices per case due to inflation
ACQUISITIONS - Co said recent acquisitions contributed to net sales and gross profit growth
Company press release: ID:nBw5Yg6n8a
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q1 Sales |
Meet |
$18.02 bln |
$18.02 bln (10 Analysts) |
Q1 Adjusted EPS |
Beat |
$1.32 |
$1.28 (10 Analysts) |
Q1 EPS |
|
$0.82 |
|
Q1 Net Income |
|
$129.50 mln |
|
Q1 Adjusted EBITDA |
Beat |
$528 mln |
$522.11 mln (10 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the food retail & distribution peer group is "buy"
Wall Street's median 12-month price target for Performance Food Group Company is $130.00, about 34.7% above its November 3 closing price of $96.51
The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 20 three months ago
Reuters Recommended Reads
Nov 3 - Sysco Q1 sales rise 2.8% but miss estimates
Nov 3 - Marzetti Q1 sales slightly miss, profit falls on cyclospora outbreak, higher costs
Nov 3 - Food distributor Sysco says cyclosporiasis outbreak hit Q1 sales
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A Hyperliquid whale is holding 12,090 AVAX short positions with an unrealized profit of $404,900.

Veteran Investor Is Expecting Biggest XRP Bull Cycle Ever
Meta Launches Muse Ember Model to Enhance Complex Reasoning Capabilities
